2018-1218 {� �} New Listing - Rapid Dose Therapeutics Corp. (DOSE)
le 14 d{� �}cembre/December 2018
The common shares of Rapid Dose Therapeutics Corp., have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on
the trading date.
|
thecse.com
Rapid Dose Therapeutics Corp. is a Canadian biotechnology corporation engaged in the business of developing and providing proprietary oral and non-invasive drug delivery technologies designed for applications in the nutraceutical, cannabis and pharmaceutical
businesses.
|
Rapid Dose Therapeutics Corp. is a Canadian biotechnology corporation engaged in the business of developing and providing proprietary oral and non-invasive drug delivery technologies designed
for applications in the nutraceutical, cannabis and pharmaceutical businesses.
________________________
Les actions ordinaires de Rapid Dose Therapeutics Corp. ont {� �}t{� �} approuv{� �}es {� �} la cote du CSE.
Les documents de cotation et d'information seront disponibles sur
www.thecse.com {� �} la date de n{� �}gociation.
Rapid Dose Therapeutics Corp. est une soci{� �}t{� �} canadienne de biotechnologie sp{� �}cialis{� �}e dans le d{� �}veloppement et la fourniture de technologies exclusives d'administration de m{� �}dicaments par
voie orale et non invasive con{� �}ues pour des applications dans les secteurs des nutraceutiques, du cannabis et des produits pharmaceutiques.
|
Issuer/{� �}metteur:
|
Rapid Dose Therapeutics Corp.
|
|
Security Type/Titre:
|
Common Shares/Actions ordinaires
|
|
Symbol(s)/Symbole(s):
|
DOSE
|
|
Number of securities issued and outstanding/ Titres {� �}mis et en circulation:
|
75 021 327
|
|
Number of Securities reserved for issuance/ Titres r{� �}serv{� �}s pour {� �}mission:
|
8 342 132
|
|
CSE Sector/Cat{� �}gorie:
|
Life Sciences/Sciences biologiques
|
|
CUSIP:
|
75339A 10 1
|
|
ISIN:
|
CA 75339A 10 1 2
|
|
Boardlot/Quotit{� �}:
|
500
|
|
Trading Currency/Monnaie de n{� �}gociation:
|
CDN$/$CDN
|
|
Trading Date/Date de negociation:
|
le 17 d{� �}cembre/December 2018
|
|
Other Exchanges/Autres marches:
|
N/A
|
|
Fiscal Year end /Cl{� �}ture de l'exercice financier:
|
Le 28 f{� �}vrier/February
|
|
Transfer Agent/Agent des transferts:
|
Capital Transfer Agency
|
The Exchange is accepting Market Maker applications for DOSE. Please email:
Trading@theCSE.com
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Pour toute question, pour obtenir de l{� �}information suppl{� �}mentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel {� �} l{� �}adresse: Listings@thecse.com
To unsubscribe, click
here.